Pediatric Delirium

• Status: Recruiting
• Trial end date: 2023-08-30
• Target enrollment: 0
• Participant gender: All

Summary

Preventing emergent delirium in pediatric ambulatory surgery through preoperative use of intra-nasal Dexmedetomidine and oral Midazolam.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Massachusetts, Worcester
• Treatments: Dexmedetomidine; Midazolam

Criteria

Inclusion Criteria:

• Subjects age 3 months to 9 years

• Scheduled to undergo a myringotomy

• American Society of Anesthesiologists (ASA) classification of I - II.

Exclusion Criteria:

• Subjects with unrepaired cardiac defects, including cyanotic congenital heart disease.

• Anyone age 10 years or older.

• Anyone with an ASA classification of III or higher.

• Non-English language speaker for whom short form consent is not available.